Product Information
CEFTRIAXONE 1 GM VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.4274 per EA under NDC 00143985725. Its NADAC has been published 362 times since Nov 28, 2013.
Strength
1 g/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143985725
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
6/17/2026
Active Ingredients
CEFTRIAXONE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA065342On Market Since
1/10/2008
Pharmacological Classes
Price Statistics
The NADAC for CEFTRIAXONE 1 GM VIAL has been published 362 times since Nov 28, 2013, and over the history we have for it it has declined 34.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4274 per EA |
|---|---|
| All-time high | $2.5349 (Aug 12, 2015) |
| All-time low | $1.4263 (Mar 18, 2026) |
| 52-week high | $1.5617 |
| 52-week low | $1.4263 |
| Median price | $1.8270 |
| Average price | $1.8105 |
| Largest weekly change | +47.9% (Jun 17, 2015) |
| Weeks tracked | 362 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFTRIAXONE 1 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFTRIAXONE 1 GM VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $1.4274 per EA (NDC 00143985725), effective Jun 24, 2026.
How has the price of CEFTRIAXONE 1 GM VIAL changed over time?
Over the history we have for it, the NADAC for CEFTRIAXONE 1 GM VIAL has declined 34.8%. It has been tracked across 362 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFTRIAXONE 1 GM VIAL?
Since Nov 28, 2013, the NADAC for CEFTRIAXONE 1 GM VIAL has ranged from a low of $1.4263 (Mar 18, 2026) to a high of $2.5349 (Aug 12, 2015), with a median of $1.8270 per EA.
Are there cheaper alternatives to CEFTRIAXONE 1 GM VIAL?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CEFTRIAXONE 1 GM VIAL, but none are currently priced below it.
Who manufactures CEFTRIAXONE 1 GM VIAL?
CEFTRIAXONE 1 GM VIAL (NDC 00143985725) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification